Literature DB >> 25986054

Human mononuclear phagocyte system reunited.

Muzlifah Haniffa1, Venetia Bigley2, Matthew Collin3.   

Abstract

The human mononuclear phagocyte network comprises dendritic cells (DCs), monocytes and macrophages with a range of immune functions including antigen presentation linking innate and adaptive immunity. A number of DC, monocyte and macrophage subsets have been described in lymphoid and non-lymphoid tissues of mouse and human, with increased understanding of their distinct functional properties and genetic and cellular pathways of development. More recently, through comparative biology studies, a unified nomenclature of mononuclear phagocytes has begun to emerge with the identification of homologous subsets in several species. In this review, we discuss the current classification of human mononuclear phagocytes and the parallel organization of this network in the mouse. We also review the genetic control and developmental pathway of human mononuclear phagocytes and the immunological functions of the distinct subsets in health and inflammation.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  Comparative biology; Dendritic cells; Macrophages; Mononuclear phagocytes; Ontogeny

Mesh:

Year:  2015        PMID: 25986054     DOI: 10.1016/j.semcdb.2015.05.004

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  49 in total

Review 1.  Lipid Metabolism in Tumor-Associated Macrophages.

Authors:  Yuancai Xiang; Hongming Miao
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  [Pulmonary Langerhans cell histiocytosis].

Authors:  H H Popper
Journal:  Pathologe       Date:  2015-09       Impact factor: 1.011

Review 3.  The influence of skin microorganisms on cutaneous immunity.

Authors:  Yasmine Belkaid; Samira Tamoutounour
Journal:  Nat Rev Immunol       Date:  2016-05-27       Impact factor: 53.106

4.  Preferential Destruction of Interstitial Macrophages over Alveolar Macrophages as a Cause of Pulmonary Disease in Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Yanhui Cai; Chie Sugimoto; Mariluz Arainga; Cecily C Midkiff; David Xianhong Liu; Xavier Alvarez; Andrew A Lackner; Woong-Ki Kim; Elizabeth S Didier; Marcelo J Kuroda
Journal:  J Immunol       Date:  2015-10-02       Impact factor: 5.422

Review 5.  Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives.

Authors:  Umar Mehraj; Hina Qayoom; Manzoor A Mir
Journal:  Breast Cancer       Date:  2021-03-04       Impact factor: 4.239

6.  Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.

Authors:  Sean Allen; Yu-Gang Liu; Evan Scott
Journal:  Regen Eng Transl Med       Date:  2016-03-03

Review 7.  Non-neoplastic histiocytic and dendritic cell disorders in lymph nodes.

Authors:  Caoimhe Egan; Elaine S Jaffe
Journal:  Semin Diagn Pathol       Date:  2017-11-03       Impact factor: 3.464

8.  Tailoring Nanostructure Morphology for Enhanced Targeting of Dendritic Cells in Atherosclerosis.

Authors:  Sijia Yi; Sean David Allen; Yu-Gang Liu; Brian Zhou Ouyang; Xiaomo Li; Punn Augsornworawat; Edward Benjamin Thorp; Evan Alexander Scott
Journal:  ACS Nano       Date:  2016-12-09       Impact factor: 15.881

Review 9.  Macrophages and cellular immunity in Drosophila melanogaster.

Authors:  Katrina S Gold; Katja Brückner
Journal:  Semin Immunol       Date:  2016-04-23       Impact factor: 11.130

10.  Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors.

Authors:  Alexandra-Chloé Villani; Rahul Satija; Gary Reynolds; Siranush Sarkizova; Karthik Shekhar; James Fletcher; Morgane Griesbeck; Andrew Butler; Shiwei Zheng; Suzan Lazo; Laura Jardine; David Dixon; Emily Stephenson; Emil Nilsson; Ida Grundberg; David McDonald; Andrew Filby; Weibo Li; Philip L De Jager; Orit Rozenblatt-Rosen; Andrew A Lane; Muzlifah Haniffa; Aviv Regev; Nir Hacohen
Journal:  Science       Date:  2017-04-21       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.